Elsevier

Molecular Diagnosis

Volume 2, Issue 3, September 1997, Pages 197-204
Molecular Diagnosis

Original Research
CD44 expression in benign and neoplastic human prostates*

https://doi.org/10.1016/S1084-8592(97)80029-XGet rights and content

Background:

CD44, a major cell surface receptor for hyaluronic acid, is a family of ubiquitous cell surface glycoproteins. Altered levels of CD44 expression, seen in many epithelial neoplasms, have prognostic implications. Expression of standard and variant isoforms of CD44 was assessed in normal and neoplastic human prostate tissue and culture cells to evaluate as a marker for malignant transformation.

Methods and Results:

Expression of CD44s, CD44R, v5, v6, v7/8 and v10 was assessed in prostate tissue (benign and malignant) and cell lines (DU-145, PC-3, LNCaP, p69) and primary cultures of normal prostates and adenocarcinoma cells obtained from prostatectomies using reverse transcriptor polymerase chain reaction, Western blotting, and immunofluorescence. No CD44 expression was seen in LNCaP cells. p69, DU-145, and PC-3 cells expressed CD44s and CD44R. p69 cells demonstrated a 1000-bp-long form of CD44 mRNA, unique to this normal cell line. Both normal and neoplastic prostatic tissue demonstrated CD44s on Western blotting.

Conclusions:

In agreement with previous studies, prostatic adenocarcinoma cells, except LNCaP, expressed CD44s. Different patterns of CD44 expression were seen in benign and neoplastic prostate. Benign prostate exhibited higher v5 protein levels, whereas neoplastic prostates demonstrated higher CD44s expression. CD44s expression was identified in all neoplastic prostates as compared with only 50% of the benign prostates. No significant difference in expression of the other variants assessed (v6, v7, v7/8, and v10) was observed in the benign and neoplastic prostates.

References (40)

  • KrillD et al.

    A simple method for the culture of primary prostate cells from benign and neoplastic prostates

    Urology

    (1997)
  • FinnL et al.

    Alternative splicing of CD44 pre-mRNA in human colorectal tumors

    Biochem Biophys Res Commun

    (1994)
  • FoxSB et al.

    Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms

    Cancer Res

    (1994)
  • UnderhillC

    CD44: The hyaluronan receptor

    J Cell Sci

    (1992)
  • ScreatonGR et al.

    Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

  • HofmannM et al.

    CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines

    Cancer Res

    (1991)
  • BrownTA et al.

    Human keratinocytes express a new CD44 core protein (CD44E) as a heparin-sulfate intrinsic membrane proteoglycan with additional exons

    J Cell Biol

    (1991)
  • DoughertyGJ et al.

    Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte “homing” receptor expressed by hemopoietic cells

    J Exp Med

    (1991)
  • JalkanenS et al.

    Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

    J Cell Biol

    (1992)
  • WaynerEA et al.

    Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits

    J Cell Biol

    (1987)
  • Cited by (0)

    *

    Supported by the Pathology Education and Research Foundation and the University of Pittsburgh Cancer Institute, Grant P30-CA 69855.

    View full text